Actigraphy Monitoring Wearables in Clinical Trials: Overcoming Barriers to Adoption & Strategies for Successful Technology Implementation

New and emerging digital technologies offer clinical trial sponsors an unprecedented opportunity to capture a wide variety of real-world, patient-generated data. One of the more prevalent tools within this rapidly evolving mHealth ecosystem are medical-grade wearable actigraphy monitoring systems, which are increasingly being used in clinical trials to collect objective physical activity and sleep-related patient outcomes.

In this white paper, ActiGraph experts discuss several common perceived barriers to actigraphy adoption and identify strategies to help sponsors develop a successful technology implementation plan and navigate the common challenges that can derail any mHealth data collection initiative, including:

• Data quality and meaningful interpretation
• Adoption costs and uncertain ROI
• Increased study complexity
• Regulatory concerns
• Patient adherence and burden

Authors

• Jeremy Wyatt, CEO, ActiGraph
• Genevieve Baley, Head of Marketing, ActiGraph